Possible role of glycogen accumulation in B-cell glucotoxicity
- PMID: 1640857
- DOI: 10.1016/0026-0495(92)90160-c
Possible role of glycogen accumulation in B-cell glucotoxicity
Abstract
Rat pancreatic islets cultured for 1 to 5 days in the presence of 20 to 80 mmol/L D-glucose accumulate glycogen in a time- and concentration-dependent manner. When the glycogen-rich islets are incubated for 6 to 10 minutes in the absence of D-glucose, the rate of glycogenolysis is grossly proportional to the glycogen content. Exogenous D-glucose (7 to 20 mmol/L) inhibits glycogenolysis. This inhibitory effect opposes the increase in glycolytic flux attributable to the utilization of exogenous glucose. Both the inhibitory effect of D-glucose on glycogenolysis and the utilization of exogenous hexose tend to be higher with alpha- than with beta-D-glucose. In light of these findings, it is proposed that the interference of D-glucose with glycogenolysis might play a role in the paradoxical changes in insulin output and its altered anomeric specificity in response to D-glucose administration, as is often encountered in non-insulin-dependent diabetic subjects and experimental models of B-cell glucotoxicity.
Similar articles
-
The anomeric malaise: a manifestation of B-cell glucotoxicity.Horm Metab Res. 1991 Jul;23(7):307-11. doi: 10.1055/s-2007-1003684. Horm Metab Res. 1991. PMID: 1774015 Review.
-
Interference of glycogenolysis with glycolysis in pancreatic islets from glucose-infused rats.J Clin Invest. 1993 Feb;91(2):432-6. doi: 10.1172/JCI116219. J Clin Invest. 1993. PMID: 8432852 Free PMC article.
-
Glycogen accumulation in rat pancreatic islets: in vitro experiments.Endocrine. 2001 Apr;14(3):303-9. doi: 10.1385/ENDO:14:3:303. Endocrine. 2001. PMID: 11444426
-
Effect of repaglinide upon nutrient metabolism, biosynthetic activity, cationic fluxes and insulin release in rat pancreatic islets.Res Commun Mol Pathol Pharmacol. 1998 Feb;99(2):155-68. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9583090
-
On the track to the beta-cell.Diabetologia. 2001 Apr;44(4):393-406. doi: 10.1007/s001250051635. Diabetologia. 2001. PMID: 11357468 Review.
Cited by
-
Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells.PLoS One. 2020 Sep 22;15(9):e0236081. doi: 10.1371/journal.pone.0236081. eCollection 2020. PLoS One. 2020. PMID: 32960890 Free PMC article.
-
The role of sulphonylureas in the management of type 2 diabetes mellitus.Drugs. 2004;64(12):1339-58. doi: 10.2165/00003495-200464120-00006. Drugs. 2004. PMID: 15200348 Review.
-
Glycogen phosphorylase inhibition improves beta cell function.Br J Pharmacol. 2018 Jan;175(2):301-319. doi: 10.1111/bph.13819. Epub 2017 Jun 18. Br J Pharmacol. 2018. PMID: 28409826 Free PMC article.
-
The Metabolic Syndrome: Emerging Novel Insights Regarding the Relationship between the Homeostasis Model Assessment of Insulin Resistance and other Key Predictive Markers in Young Adults of Western Algeria.Nutrients. 2020 Mar 10;12(3):727. doi: 10.3390/nu12030727. Nutrients. 2020. PMID: 32164195 Free PMC article. Clinical Trial.
-
Effect of repaglinide on insulin secretion in islets from rats infused for two days with a hypertonic solution of D-glucose.Endocrine. 1998 Jun;8(3):247-50. doi: 10.1385/ENDO:8:3:247. Endocrine. 1998. PMID: 9741829
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources